Back

Need for more evidence of safety in the pharmacological therapy of anaemia in chronic kidney disease: a cardiovascular perspective

European Heart Journal - Cardiovascular Pharmacotherapy

30 April 2022
Organised by: Logo
Read full article
ESC Journals

Contributors

Atsushi Tanaka
Atsushi Tanaka

Author

Saga University Saga , Japan

Koichi Node
Koichi Node

Author

Saga University Saga , Japan

You may be interested in
thumbnail
Congress Presentation
Exploring the hemoglobin-cardiovascular link in chronic kidney disease patients
19 May 2025
thumbnail
Congress Presentation
Efficacy of intravenous and oral iron replacement therapies in heart failure: a network meta-analysis
1 September 2025
thumbnail
Congress Presentation
Efficacy and safety of sacubitril-valsartan in heart failure with reduced ejection fraction in end-stage renal patients.
20 May 2023
thumbnail
Congress Presentation
Hepcidin and cardiovascular events in patients with chronic kidney disease undergoing dialysis: a post-hoc analysis of the ASCEND-D trial
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources